tiprankstipranks
scPharmaceuticals Inc (SCPH)
NASDAQ:SCPH
US Market

scPharmaceuticals (SCPH) Financial Statements

246 Followers

scPharmaceuticals Financial Overview

scPharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.421; its P/E ratio is -4.10; scPharmaceuticals is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 3.80M$ 1.64M-$ 34.00K$ 0.00
Gross Profit$ 2.72M$ 1.64M$ -605.00K$ 34.00K-
EBIT$ -12.49M$ -11.79M$ -10.56M$ -8.14M$ -9.79M
EBITDA$ -12.92M$ -12.04M$ -10.98M$ -8.22M$ -9.67M
Net Income Common Stockholders$ -15.63M$ -14.15M$ -11.21M$ -9.25M$ -10.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 90.20M$ 102.88M$ 116.07M$ 118.37M$ 45.19M
Total Assets$ 106.10M$ 114.17M$ 127.32M$ 124.19M$ 48.40M
Total Debt$ 39.81M$ 38.01M$ 37.68M$ 37.37M$ 10.59M
Net Debt$ -50.38M$ -64.86M$ -78.39M$ -81.00M$ -34.60M
Total Liabilities$ 56.95M$ 50.74M$ 51.56M$ 51.76M$ 17.29M
Stockholders Equity$ 49.15M$ 63.43M$ 75.85M$ 72.43M$ 31.11M
Cash Flow-
Free Cash Flow$ -13.45M$ -14.14M$ -16.49M$ -11.86M$ -8.21M
Operating Cash Flow$ -13.45M$ -14.14M$ -16.49M$ -11.86M$ -8.20M
Investing Cash Flow$ -22.93M$ 9.43M$ 7.00M$ -42.99M$ 10.78M
Financing Cash Flow$ 68.00K$ 611.00K$ 13.70M$ 84.60M$ -2.48M
Currency in USD

scPharmaceuticals Earnings and Revenue History

scPharmaceuticals Debt to Assets

scPharmaceuticals Cash Flow

scPharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis